IONS
Ionis Pharmaceuticals, Inc.
Stock
$43.54−0.46 (−1.05%)Close Oct 2, 2026
- Research and development, 2025
- $916M
- YoY, 2025
- +1.6%
- 5-year CAGR
- +11.5%
- 10-year CAGR
- +11.1%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $916M | +1.6% |
| 2024 | $902M | +0.2% |
| 2023 | $900M | — |
| 2021 | $638M | +20.2% |
| 2020 | $531M | +15.1% |
| 2019 | $462M | +12.0% |
| 2018 | $412M | +10.6% |
| 2017 | $373M | +9.4% |
| 2016 | $340M | +6.5% |
| 2015 | $320M | +33.7% |
| 2014 | $239M | +37.5% |
| 2013 | $174M | +12.4% |
| 2012 | $155M | +1.0% |
| 2011 | $153M | +5.5% |
| 2010 | $145M | +7.8% |
| 2009 | $135M | +26.5% |
| 2008 | $106M | — |